{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:12:04Z","timestamp":1761844324621},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/inf.0000000000000329","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T15:36:34Z","timestamp":1395243394000},"page":"865-871","source":"Crossref","is-referenced-by-count":11,"title":["Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children"],"prefix":"10.1097","volume":"33","author":[{"given":"Karen L.","family":"Kotloff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha B.","family":"Halasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet A.","family":"Englund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Buddy","family":"Creech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena J.","family":"Dolor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana L.","family":"Noah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/515616","article-title":"Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.","volume":"178","author":"Simonsen","year":"1998","journal-title":"J Infect Dis"},{"key":"R2-22-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/655904","article-title":"Emerging Infections Program Network. Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States.","volume":"202","author":"Dao","year":"2010","journal-title":"J Infect Dis"},{"key":"R3-22-20210202","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2010.05.012","article-title":"Emerging Infections Program Network. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008.","volume":"157","author":"Dawood","year":"2010","journal-title":"J Pediatr"},{"key":"R4-22-20210202","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States.","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"R7-22-20210202","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"key":"R8-22-20210202","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/jama.2009.1583","article-title":"California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.","volume":"302","author":"Louie","year":"2009","journal-title":"JAMA"},{"key":"R9-22-20210202","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/652441","article-title":"Recipients of vaccine against the 1976 swine flu have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.","volume":"50","author":"McCullers","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R10-22-20210202","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"R11-22-20210202","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children.","volume":"8","author":"Jefferson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-22-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1542\/peds.2007-3304","article-title":"New Vaccine Surveillance Network. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons.","volume":"122","author":"Eisenberg","year":"2008","journal-title":"Pediatrics"},{"key":"R13-22-20210202","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1542\/peds.2006-1878","article-title":"Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.","volume":"119","author":"Shuler","year":"2007","journal-title":"Pediatrics"},{"key":"R14-22-20210202","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1086\/527391","article-title":"A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings.","volume":"46","author":"Madan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R15-22-20210202","first-page":"1095","article-title":"Trivalent, inactivated influenza virus vaccine in children with sickle cell disease.","volume":"137","author":"Glezen","year":"1983","journal-title":"Am J Dis Child"},{"key":"R16-22-20210202","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"R17-22-20210202","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"key":"R18-22-20210202","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/591465","article-title":"Increasing doses of an inactivated influenza AH1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.","volume":"198","author":"Keitel","year":"2008","journal-title":"J Infect Dis"},{"key":"R19-22-20210202","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1750-2659.2011.00250.x","article-title":"Confronting the next pandemic-workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010.","volume":"5","author":"Hardy","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"R20-22-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza ADuckSingapore97 vaccine.","volume":"103","author":"Stephenson","year":"2004","journal-title":"Virus Res"},{"key":"R21-22-20210202","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R22-22-20210202","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/JCM.23.2.240-245.1986","article-title":"Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses.","volume":"23","author":"Walls","year":"1986","journal-title":"J Clin Microbiol"},{"key":"R24-22-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200001273420401","article-title":"The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.","volume":"342","author":"Neuzil","year":"2000","journal-title":"N Engl J Med"},{"key":"R25-22-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"New Vaccine Surveillance Network. The underrecognized burden of influenza in young children.","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"R26-22-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(09)62026-2","article-title":"Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.","volume":"375","author":"Plennevaux","year":"2010","journal-title":"Lancet"},{"key":"R27-22-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2009.1911","article-title":"Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.","volume":"303","author":"Nolan","year":"2010","journal-title":"JAMA"},{"key":"R28-22-20210202","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","article-title":"A novel influenza A (H1N1) vaccine in various age groups.","volume":"361","author":"Zhu","year":"2009","journal-title":"N Engl J Med"},{"key":"R29-22-20210202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jama.2009.1929","article-title":"2009 influenza A(H1N1) monovalent vaccines for children.","volume":"303","author":"Fiore","year":"2010","journal-title":"JAMA"},{"key":"R30-22-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/infdis\/jis306","article-title":"Effectiveness of 1 dose of 2009 influenza A (H1N1) vaccine at preventing hospitalization with pandemic H1N1 influenza in children aged 7 months-9 years.","volume":"206","author":"Hadler","year":"2012","journal-title":"J Infect Dis"},{"key":"R31-22-20210202","doi-asserted-by":"crossref","first-page":"e23085","DOI":"10.1371\/journal.pone.0023085","article-title":"U.S. Flu-VE Network. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.","volume":"6","author":"Griffin","year":"2011","journal-title":"PLoS One"},{"key":"R32-22-20210202","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/infdis\/jis441","article-title":"Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.","volume":"206","author":"Uzicanin","year":"2012","journal-title":"J Infect Dis"},{"key":"R33-22-20210202","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","article-title":"Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"R34-22-20210202","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jpeds.2006.06.036","article-title":"Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season.","volume":"149","author":"Allison","year":"2006","journal-title":"J Pediatr"},{"key":"R35-22-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1542\/peds.2005-0049","article-title":"Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses.","volume":"116","author":"Ritzwoller","year":"2005","journal-title":"Pediatrics"},{"key":"R36-22-20210202","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1542\/peds.2006-0725","article-title":"CAIV-T Pediatric Day Care Clinical Trial Network. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.","volume":"118","author":"Vesikari","year":"2006","journal-title":"Pediatrics"},{"key":"R37-22-20210202","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children.","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"R38-22-20210202","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/INF.0b013e31825e6cd6","article-title":"Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to 9 years of age: safety and immunogenicity.","volume":"31","author":"Langley","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R39-22-20210202","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1542\/peds.2010-3492","article-title":"Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.","volume":"128","author":"Gilca","year":"2011","journal-title":"Pediatrics"},{"key":"R40-22-20210202","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1016\/j.vaccine.2012.07.009","article-title":"Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.","volume":"30","author":"Ortqvist","year":"2012","journal-title":"Vaccine"},{"key":"R41-22-20210202","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children.","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"},{"key":"R42-22-20210202","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"R44-22-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1473-3099(10)70255-3","article-title":"Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study.","volume":"11","author":"Heinonen","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"RR-8","key":"R45-22-20210202","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R46-22-20210202","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3476(76)80721-4","article-title":"Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine.","volume":"88","author":"Marine","year":"1976","journal-title":"J Pediatr"},{"key":"R47-22-20210202","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/136.5.623","article-title":"A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children.","volume":"136","author":"Gross","year":"1977","journal-title":"J Infect Dis"},{"key":"R48-22-20210202","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1542\/peds.2010-2777","article-title":"Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months.","volume":"128","author":"Skowronski","year":"2011","journal-title":"Pediatrics"},{"key":"R50-22-20210202","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1086\/319863","article-title":"National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET). Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.","volume":"183","author":"Belshe","year":"2001","journal-title":"J Infect Dis"},{"key":"R51-22-20210202","doi-asserted-by":"crossref","first-page":"e39435","DOI":"10.1371\/journal.pone.0039435","article-title":"Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains.","volume":"7","author":"Carter","year":"2012","journal-title":"PLoS One"},{"key":"R52-22-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMc0909988","article-title":"Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.","volume":"362","author":"Arguedas","year":"2010","journal-title":"N Engl J Med"},{"key":"R53-22-20210202","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1016\/j.vaccine.2012.04.044","article-title":"Pandemic H1N1 Vaccine Adult Study Group. Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.","volume":"30","author":"Chen","year":"2012","journal-title":"Vaccine"},{"key":"R54-22-20210202","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/jis445","article-title":"Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.","volume":"206","author":"Frey","year":"2012","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:03:30Z","timestamp":1620954210000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201408000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000329","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}